Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 2 (2005), Issue 12 (December)

1. Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable.
   Br J Surg, 92(12): 1533-8. [Abstract] [Full-text]
2. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
   Clin Cancer Res, 11(23): 8492-502. [Abstract] [Full-text]
3. Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin.
   Clin Cancer Res, 11(23): 8476-85. [Abstract] [Full-text]
4. Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins.
   Cancer Res, 65(23): 11129-35. [Abstract] [Full-text]
5. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease.
   Cancer Res, 65(23): 10938-45. [Abstract] [Full-text]
6. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.
   Science, 310(5753): 1504-10. [Abstract] [Full-text]
7. Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
   Oncogene, 24(54): 7955-63. [Abstract] [Full-text]
8. Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations.
   Int J Cancer, 118(3): 600-8. [Abstract] [Full-text]
9. Occupational factors and risk of adult bone sarcomas: a multicentric case-control study in Europe.
   Int J Cancer, 118(3): 721-7. [Abstract] [Full-text]
10. Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells.
    Int J Cancer, 118(3): 532-9. [Abstract] [Full-text]
11. Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells.
    Int J Cancer, 118(3): 571-6. [Abstract] [Full-text]
12. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
    Int J Cancer, 118(3): 540-6. [Abstract] [Full-text]
13. Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells.
    Int J Cancer, 118(3): 547-54. [Abstract] [Full-text]
14. An examination of characteristics of lung and colon cancer patients participating in a web-based decision support program. Internet-based decision support programs.
    Oncology, 69(4): 311-6. [Abstract] [Full-text]
15. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.
    Br J Cancer, 93(12): 1356-63. [Abstract] [Full-text]
16. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
    JAMA, 294(21): 2703-11. [Abstract] [Full-text]
17. Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.
    Br J Cancer, 93(12): 1350-5. [Abstract] [Full-text]
18. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma.
    Br J Cancer, 93(12): 1364-71. [Abstract] [Full-text]
19. Expression of VDR and CYP24A1 mRNA in human tumors.
    Cancer Chemother Pharmacol, 57(2): 234-40. [Abstract] [Full-text]
20. Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.
    J Clin Oncol, 23(35): 8950-8. [Abstract] [Full-text]
21. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Cancer Chemother Pharmacol, 57(2): 171-9. [Abstract] [Full-text]
22. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.
    J Pathol, 208(1): 91-9. [Abstract] [Full-text]
23. Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
    Cancer Immunol Immunother, 55(1): 47-55. [Abstract] [Full-text]
24. Inclusion of vasculature-related variables in the Dukes staging system of colon cancer.
    Clin Cancer Res, 11(24): 8653-60. [Abstract] [Full-text]
25. Repeat hepatectomy for recurrent colorectal liver metastases.
    J Surg Oncol, 93(1): 1-7. [Abstract] [Full-text]
26. Overexpression of ADAM9 enhances growth factor-mediated recycling of E-cadherin in human colon cancer cell line HT29 cells.
    Exp Cell Res, 312(3): 331-9. [Abstract] [Full-text]
27. Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis.
    Exp Cell Res, 312(3): 350-61. [Abstract] [Full-text]
28. Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case.
    Dis Colon Rectum, 48(11): 2148-52. [Abstract] [Full-text]
29. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case.
    Dis Colon Rectum, 48(11): 2144-7. [Abstract] [Full-text]
30. Laparoscopic vs. open colectomies in octogenarians: a case-matched control study.
    Dis Colon Rectum, 48(11): 2070-5. [Abstract] [Full-text]
31. Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells.
    Int J Cancer, 118(5): 1309-15. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.